INS and type 2 diabetes mellitus: These findings open new perspectives, encouraging the search of other less harmful antifolates that, either by inhibiting AICAR transformylase or by increasing AICAR in vivo production, might have a potential application for the treatment of type 2 diabetes and other insulin-resistant conditions.